Cronos Group (CVE:MJN) Stock Price Down 1.9% – Should You Sell?

Cronos Group Inc (CVE:MJN) shares dropped 1.9% during mid-day trading on Friday . The company traded as low as C$11.90 and last traded at C$12.15. Approximately 1,388,975 shares changed hands during trading, a decline of 33% from the average daily volume of 2,065,952 shares. The stock had previously closed at C$12.38.

Cronos Group Price Performance

The stock has a fifty day simple moving average of C$12.15 and a two-hundred day simple moving average of C$12.15.

Cronos Group Company Profile

Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada’s Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals.